A long-established general cancer research journal founded by the International Union Against Cancer, spanning cancer biology, epidemiology and clinical research. Read by cancer researchers worldwide.
International Journal of Cancer is published by Wiley (John Wiley & Sons), which Crossref lists as its publisher. The NLM Catalog records that it began in 1966 in Geneva, issued by the International Union Against Cancer with assistance from the US National Institutes of Health and the Calouste Gulbenkian Foundation, moved to Wiley-Liss in New York in 1995, and now appears thirty times a year; articles have historically been in English or French with a summary in the other language, and the title is indexed in MEDLINE.
The current honest statement of where early detection stands: no blood test is ready, and the research is about finding the threshold at which to operate.
For the first time clinicians have an agreed answer to who to screen for anal cancer and at what age, so that treatment of HSIL can reach the people most likely to benefit.
This is the paper Europe PMC returns for registry id NCT04454437 with the most citations, so it is the natural first reading for anyone following the trial. Read the abstract above alongside the trial page and the registry entry; the record was linked automatically and its figures have not been checked by hand.
This is the methods and overview companion to the widely cited Sung 2021 report and the reference for how the 2020 figures were built.
This paper is the place to check how solid a given country's GLOBOCAN 2018 figure is, which matters when the numbers are used to argue for national cancer plans.
Anyone using GLOBOCAN numbers should know how they are produced; this paper explains the method hierarchy and why figures for countries without good registries carry wide uncertainty.
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Radiation oncologist who chairs the directorate of the University Cancer Center Inselspital in Bern.
Pancreatic cancer surgeon-scientist who directs UC San Diego Moores Cancer Center, an NCI-designated comprehensive cancer center.
Academician who presides over the China Anti-Cancer Association, China's national oncology society with branches in every province and around 260,000 individual members.
Professor who directs the Hacettepe University Cancer Institute in Ankara, one of Turkey's leading academic cancer research and treatment institutes.
Director general who leads the Institut Català d'Oncologia, the Catalan public cancer institute that runs comprehensive cancer services across several hospital sites.
Medical oncologist who has led Cedars-Sinai Cancer in Los Angeles as Interim Director since March 2025.
Cancer epidemiologist and professor who became Director of OncoZON, the oncology network of ten hospitals in the south-east Netherlands, in August 2026.
For the first time clinicians have an agreed answer to who to screen for anal cancer and at what age, so that treatment of HSIL can reach the people most likely to benefit.
This is the paper Europe PMC returns for registry id NCT04454437 with the most citations, so it is the natural first reading for anyone following the trial. Read the abstract above alongside the trial page and the registry entry; the record was linked automatically and its figures have not been checked by hand.
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Shares Fan Daiming, PubMed & Europe PMC.
Shares Robert Figlin, PubMed & Europe PMC.
Shares Fan Daiming, PubMed & Europe PMC.